Name
Tabasalu Apteek OÜ
Registry code
14036585
VAT number
EE102177514
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
22.04.2016 (8)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
0 €
-85 €
-
-
-42 981 €
0
Submitted
No tax arrears
0%
-24%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Maija Tressum 10.05.1952 (72) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| 2019 02.10.2020 | 2020 22.06.2021 | 2021 15.06.2022 | 2022 21.06.2023 | 2023 18.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 56 233 € | 260 945 € | 303 401 € | 180 253 € | 0 € |
| Net profit (loss) for the period | -15 945 € | -15 544 € | -7 018 € | -4 390 € | -85 € |
| Profit Margin | -28% | -6% | -2% | -2% | - |
| Current Assets | 47 618 € | 53 132 € | 47 287 € | 437 € | 352 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 47 618 € | 53 132 € | 47 287 € | 437 € | 352 € |
| Current Liabilities | 63 563 € | 84 621 € | 85 793 € | 43 333 € | 43 333 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | -15 945 € | -31 489 € | -38 506 € | -42 896 € | -42 981 € |
| Employees | 2 | 2 | 1 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | - | - | - | - |
| 2023 Q3 | - | - | - | - |
| 2023 Q2 | - | - | - | - |
| 2023 Q1 | - | - | - | - |
| 2022 Q4 | - | - | - | - |
| 2022 Q3 | 72 384.71 € | 9 872.82 € | 4 468.6 € | - |
| 2022 Q2 | 65 939.93 € | 5 187.46 € | 3 709.16 € | 3 |
| 2022 Q1 | 57 274.6 € | 4 702.34 € | 3 371.76 € | 3 |
| 2021 Q4 | 97 284 € | 9 361.87 € | 5 597.73 € | 3 |
| 2021 Q3 | 83 941.89 € | 5 835.76 € | 4 087.83 € | 3 |
| 2021 Q2 | 66 595.17 € | 5 566.99 € | 4 305.59 € | 3 |
| 2021 Q1 | 59 661.12 € | 5 788.36 € | 4 085.59 € | 4 |
| 2020 Q4 | 69 864.63 € | 6 607.63 € | 4 705.56 € | 3 |
| 2020 Q3 | 65 345.35 € | 6 529.76 € | 4 964.05 € | 4 |
| 2020 Q2 | 69 531.32 € | 4 592.13 € | 3 685.58 € | 4 |
| 2020 Q1 | 53 965.84 € | 5 612.22 € | 4 032.66 € | 4 |
